- This event has passed.
Applying for Angel Funding- Part 1: The Angel’s Perspective
February 7 @ 11:45 am - 2:00 pm
at Suffolk University - Sargent Hall
Free - $35Event Navigation
Not all angel groups are created equal. Hear from the leaders of the top angel groups in Boston on where to begin when you are approaching angel groups. Learn what to expect, what they like to see, and how to make your application and pitch stand out.
Questions answered will include:
- How do you approach angel groups?
- How do you get a Champion?
- What are the most important parts of the application? What aspects of my company will Angels care most about?
- What is the best way to prepare for your pitch to an angel group?
- What about the JOBs act - how has that changed the landscape?
Jodi Collier
Executive Director at Launchpad Venture Group
Jodi Collier is the Executive Director for Launchpad Venture Group where she helps manage deal flow and provides support to the membership, applying entrepreneurs and portfolio CEOs. Prior to joining Launchpad, Jodi worked at Champion International Paper Company (later acquired by International Paper) and was the Vice President of EF Education First where she had over 10 years of marketing and operations experience in the education and manufacturing industries.
Kathryn Roy
Angel Investor at Walnut Ventures
Kathryn Roy headed up marketing at several major technology companies, including Boston’s iconic Lotus Development Corporation. In her consulting practice, she has advised companies ranging from IBM to Constant Contact. Her concentration is getting messaging right. She brings that focus to her angel investing at Walnut Ventures, giving founders deeply considered advice on their approach to markets.
Jeff Arnold
Angel Investor at Boston Harbor Angels & Mass Medical Angels
Jeff is an angel investor with Mass Medical Angels and Boston Harbor Angels. He also serves as a strategic advisor to early and growth stage CEOs as President of Arnold Strategies, LLC. As an investor he’s had multiple exits including SmartCells (sold to Merck), BioAssets development Corp (sold to Cephalon), Syntonix (sold to Biogen Idec), Health Honors (sold to Healthway), Corbus Pharmaceuticals (now public) and Myomo (now public). He was previously chairman of Corbus Pharmaceuticals, with a phase III drug for orphan fibrotic diseases, CEO of CardioFocus, with an endoscopic catheter for atrial fibrillation, founder and CEO of Cambridge Heart, Inc., which he took public in 1996, and CEO of Accelys, now a division of Dassault Systemes.
Sheila Narayan
Managing Director at Golden Seeds
Sheila Narayan is a Managing Director at Golden Seeds where she manages their Office Hours Program and assists with deal flow activities. She is active in Boston’s entrepreneurial ecosystem, mentoring entrepreneurs and judging business competitions. She has over 20 years of experience in the payments and financial technology industries. Previously, Sheila held executive leadership roles at Online Resources, Inc. and was a Partner at First Annapolis Consulting.
Thanks to our location sponsor
Please note that TCN events are open to entrepreneurs and investors only, or approved guests of TCN. Service providers of any type must join TCN as a Sponsor. Email [email protected] for details.
Join as a member Want unlimited access to everything The Capital Network has to offer?
Join as a member for access to events and more.
